News
Sequoia India raises $195m for latest seed fund
Sequoia Capital India has closed a second seed fund under its Surge accelerator program at $195 million. Like its predecessor, it will target start-ups in India and Southeast Asia.
Gulf Capital invests $30m in India healthcare push
Abu Dhabi-based Gulf Capital has committed $30 million to a plan that will see its global fertility services platform launch 18 clinics in India over the next 12 months.
China's Baidu raises funding for chip unit at $2b valuation
CPE has led a funding round for Kunlun, the semiconductor unit of Chinese search giant Baidu, at a post-deal valuation of approximately RMB13 billion ($2 billion).
China's Zhihu completes $522m IPO, endures volatile debut
Chinese question-and-answer platform Zhihu endured a difficult New York Stock Exchange debut, closing at a 10.5% discount to its IPO price on a day when US-listed Chinese stocks fluctuated wildly.
Australia social media start-up Linktree raises $45m
Index Ventures and Coatue Management have led a $45 million Series B round for Australia-based social media services platform Linktree.
KKR, Sequoia lead $234m round for Indian NBFC
KKR and Sequoia Capital India have led a $234 million investment in Indian non-banking financial company (NBFC) Five Star Business Finance at a valuation of $1.4 billion.
PE topples advisory as China Renaissance's key business
Fund management has become China Renaissance’s largest source of revenue, seven years after the firm – best known for providing private placement and M&A advisory services to Chinese internet companies – entered the private equity business.
Baring targets $8.5b for eighth pan-Asia fund
Baring Private Equity Asia is back in the market seeking $8.5 billion for its eighth pan-regional fund, less than 15 months after closing Fund VII at $6.5 billion.
China yogurt brand secures $122m Series B
Simple Love, also known as Jian’Ai, a Chinese yogurt brand, has raised RMB800 million ($122 million) in Series B funding from Matrix Partners China, BA Capital, CITIC Agriculture Fund, and Maison Capital. They all backed the company's RMB400 million...
China autonomous driving start-up TuSimple files for US IPO
TuSimple, a China and US-based developer of autonomous driving technology for trucks, has filed for a US IPO. Its backers include CDH Investments, Zhiping Capital, Sina Corporation, and Hong Kong hedge fund Composite Capital.
India's Dream Sports raises $400m, hits $5b valuation
Dream Sports, operator of India’s largest fantasy sports platform, has raised $400 million in funding led by TCV, D1 Capital Partners and Falcon Edge Capital. The post-deal valuation is nearly $5 billion.
Hony launches China healthcare, consumer SPAC
Hony Capital has joined a string of Chinese private equity managers with special purpose acquisition vehicles (SPACs), targeting $300 million for healthcare and consumer deals.
JC Flowers exits Asia trading platforms business
JC Flowers has agreed to sell Hong Kong-based Chi-X Asia Pacific, which operates equity trading platforms in Australia and Japan, to US-based Cboe Global Markets.
IFC to invest $25m in Gaja’s fourth India fund
The International Finance Corporation (IFC) has proposed a $25 million commitment to the fourth private equity fund from India’s Gaja Capital. The target corpus is $400 million.
Invesco leads $155m round for China's Brii Biosciences
Invesco has led a $155 million Series C round for China-focused infectious diseases drug developer Brii Biosciences.
Asian GPs prioritize portfolio resilience - Bain & Co
Three out of five GPs in Asia Pacific would be willing to forego at least 5% of near-term profit if that sum could be invested in making their portfolio companies more resilient across a range of metrics.
CMB, Mirae lead Series C for China biotech player EpimAb
Shanghai-based EpimAb Biotherapeutics has raised $120 million in Series C funding led by CMB International and Korea’s Mirae Asset Financial Group.
China drug development outsourcer raises $70m
Zhenge Biotech – a Shanghai-based contract development and manufacturing organization (CDMO) for large molecule drugs – has raised $70 million in Series B funding led by Qiming Venture Partners and IDG Capital.
Blackstone bids $6.1b for Australia's Crown Resorts
The Blackstone Group has offered to acquire 100% of Australia-listed casino and hotel operator Crown Resorts for about A$8 billion ($6.1 billion).
Australia's Airwallex sees valuation hit $2.6b
Airwallex, an international payments technology provider that launched out of Melbourne, has closed a third tranche of Series D funding, taking the overall round to $300 million and its valuation to $2.6 billion.
DCM set for partial exit from Japan's Freee
Tokyo-listed accounting software provider Freee is set to raise up to JPY42.5 billion ($391 million) through an offering of new shares and the sale of shares held by DCM Ventures.
China's Taishan Beer raises $92m
CMC Capital Group has committed RMB600 million ($92 million) in funding to Chinese domestic beer brand Taishan.
CDC, FMO, SDC launch Nepal investment platform
European development finance institutions CDC Group and FMO and the Swiss Agency for Development and Cooperation (SDC) have jointly launched a market building platform in Nepal.
Bain backs China gas station platform Newlink
Bain Capital Private Equity led a $200 million investment in Newlink Group, operator of a platform that helps drivers in China locate the best value gas stations and charging piles. Joy Capital re-upped in the round.